Mexico, through CONACYT and public and private laboratories, develops a vaccine against COVID – 19
Photo: Presidency of Mexico / EFE
The president of Mexico, Andrés Manuel López Obrador, proposed to name the future vaccine “Homeland” Mexican against COVID – 19 that is developed through joint work between researchers from the National Council of Science and Technology (CONACYT) and public and private laboratories in Mexico.
“With all due respect, because they are initiatives of Conacyt, public research centers but also private companies, we are going to suggest that our vaccine be called Patria. We have already set aside the name “, said the Mexican president from the State of Oaxaca.
In a Sunday morning conference, the Mexican president proposed the name of “Patria” to the possible Mexican vaccine, emulating the projects carried out in countries like Cuba.
“ Nothing more to anticipate than just how La Soberana I is in Cuba, and that we are also very pleased that this vaccine is being developed, in There is also research in Mexico “, he pointed out.
For his part the Mexican Foreign Minister, Marcelo Ebrard, announced that through the Community of Latin American and Caribbean States, is known about the development of six vaccine projects in Latin America against COVID – 19 in countries such as Cuba ( Sovereign I and II), Chile, Brazil, Argentina and Mexico co.
“ At this moment, six vaccines in Latin America are about to start the chemical phase, of which in Cuba there are two, they are going ahead in that, because it has been the object of a blockade and they have to develop their vaccines; It is incredible because that blockade has not been modified, it is incredible, we said that in the UN General Assembly and in all forums, because it is not valid, Cuba is developing its vaccine. Like Mexico, Chile, Brazil and Argentina, of the countries that have not reported to us that chemical phases are about to start “, commented Marcelo Ebrard.
The Secretary of Foreign Relations of Mexico also reported that Mexico is interested in having access to the Cuban project of the Sovereign I and II vaccine.
The Mexican official revealed that Mexico has close ties with the American pharmaceutical company Moderna, to which he adds to the interest of the projects carried out by Curevac, Novavax and Janssen, as well as Birmex Laboratories.
Continue Reading: AMLO announces reactivation National Vaccination Plan; arrive in Mexico 870, 000 AstraZeneca vaccine dose
